#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Parvovirus B19 from the point of view of pediatric hematologist


Authors: Eva Jadvidžáková 1;  Petr Hubáček 1,2;  Zdeněk Kepka 2;  Petr Smíšek 1;  Lucie Šrámková 1;  Jan Starý 1;  Martina Suková 1
Published in: Čes-slov Pediat 2025; 80 (1): 30-35.
Category: Case Histories
doi: https://doi.org/10.55095/CSPediatrie2024/060

Overview

Jadvidžáková E, Hubáček P, Kepka Z, Smíšek P, Šrámková l, Starý J, Suková M. Parvovirus B19 from the point of view of pediatric hematologist

Parvovirus B19 is the causative agent of classical childhood illness known as the 5th disease or erythema infectiosum. the occurrence has a seasonal character, with more dominant waves every 3 to 5 years. remarkably higher incidence since 2023 is observed globally. similarly to recent distinct waves od rsV and influenza, even in this case we can suspect a connection with covid pandemic (rapid contagion after 2 years of social restrictions). the article describes a cohort of patients with pcr confirmed symptomatic parvovirus B19 infection during a period of 12 years (02/2012-06/2024) at the department of pediatric Hematology and oncology, Motol university Hospital. We do not aim at thorough epidemiological analysis, but rather focus on bringing the topic to the czech pediatric community and describe hematological variety of parvovirus B19 infection.

Keywords:

Hematology – children – parvovirus B19 – erythema infectiosum – 5th disease – aplastic crisis


Sources
  1. Cossart y, parvovirus B19 finds a disease. lancet 1981; 318: 988–989.
  2. enders m, et al. current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. epidemiol infect 2007; 135(4): 563–569.
  3. hübschen Jm, et al. phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J clin Microbiol 2009; 47(11): 3735–8.
  4. mossong J, et al. parvovirus B19 infection in five european countries: seroepidemiology, force of infection and maternal risk of infection. epidemiol infect 2008; 136: 1059–1068.
  5. Guillet m, et al. new atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. euro surveill 2024; 29(21).
  6. https://www.ecdc.europa.eu/en/publications-data/risks-posed-reported- -increased-circulation-human-parvovirus-b19-eueea
  7. d’humières C, et al. an unusual out break of parvovirus B19 infections, France, 2023 to 2024. euro surveill 2024; 29(25).
  8. patalon t, et al. an outbreak of parvovirus B19 in israel. Viruses 2023; 15: 2261.
  9. Vuković V, et al. seroepidemiology of human parvovirus B19 infection among the population of Vojvodina, serbia, over a 16-year period (2008– 2023). Viruses 2024; 16: 180.
  10. nordholm aC, et al. epidemic of parvovirus B19 and disease severity in pregnant people, denmark, January to March 2024. euro surveill 2024.
  11. https://www.ecdc.europa.eu/en/publications-data/intensified-circulation- -respiratory-syncytial-virus-rsv-and-associated-hospital
  12. https://szu.cz/aktuality/chripka-je-v-cr-dominantni-dosahla-urovne-epidemie/
  13. Weigel-kelley ka, yoder mC, srivastava a. alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003; 102(12): 3927– 33.
  14. xu m, leskinen k, Gritti t, et al. prevalence, cell tropism, and clinical impact of human parvovirus persistence in adenomatous, cancerous, inflamed, and healthy intestinal mucosa. Front Microbiol 2022; 13: 914181.
  15. Gigi, et al. parvovirus B19 infection in pregnancy – a review. eur J obstet Gynecol reprod Biol 2021; 264: 358–362.
  16. Bentata y. parvovirus B19 in kidney transplantation: keypoints and essen tail pitfalls to know. infect dis 2021; 53(6): 404–408.
  17. algwaiz G, alharbi a, alsehaim k, et al. Hematologic manifestations of parvovirus B19 infection. Hematol oncol stem cell ther 2023; 16(4): 316– 322.
  18. Vanspranghels, et al. does an intrauterine exchange transfusion improve the fetal prognosis in parvovirus infection cases? transfusion 2019; 59(1): 185–190.
  19. hu x, Jia C, Wu J, et al. towards the antiviral agents and nanotechnology-enabled approaches against parvovirus B19. Front cell infect Microbiol 2022; 12: 916012.
  20. karna B, Jha sk, al Zaabi e. Hemoglobin c disease. in: statpearls [internet]. treasure island (Fl): statpearlspublishing 2024.
  21. slavov s, et al. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FeMs immunol Med Microbiol 2011; 62: 247–262.
Labels
Neonatology Paediatrics General practitioner for children and adolescents
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#